Contract for Metal Hoses for Phase I Project of Jiangya Recombinant Protein Pharmaceuticals in Changzhou
Shanghai Songjiang Vibration Absorber Co.,Ltd. official website presents: Invoice for the Contract of Metal Hoses for Phase I Project of Jiangya Recombinant Protein Pharmaceuticals in Changzhou. The following is the purchase contract signed between Songjiang Group and China Electronics System Engineering Construction Co., Ltd., which is used for the Phase I Project of Jiangya Recombinant Protein Pharmaceuticals in Changzhou. This contract mainly includes stainless steel flange metal hoses and flange rubber joint products. Here is the detailed introduction.
1.Introduction to the Phase I Project of Jiangya Recombinant Protein Pharmaceuticals in Changzhou:
Jianya (Changzhou) Biotechnology Co., Ltd. was registered with the Changzhou New North District Market Supervision Administration on December 18, 2014. Its legal representative is Shen Chun. The company’s business scope includes the development of biopharmaceutical technology, biopharmaceutical products, and pharmaceutical intermediates.
Jianya Biotechnology has gathered more than 10 entrepreneurs, scientists, and engineers with 20-30 years of experience in the European and American biopharmaceutical industry. They have long been focused on the research and industrialization of key technologies related to insulin. Jianya Biotechnology possesses world-leading 5th generation insulin ecological industrialization production technology, leading the industry in product quality, and bringing about revolutionary technological innovations in the global insulin industry.
In 2014, Jianya Biotechnology settled in the Changzhou Life and Health Industry Park. The first phase has a registered capital of 120 million US dollars, with a total investment of 1 billion US dollars and a planned area of 800 acres. It implements a strategy of “one-time planning and design, investment and development in three phases” and aims to build a world-class 21st-century insulin ecological industrial park.
Jianya Biotechnology’s pilot platform (Phase I Project) is located in Building 4 of the Accelerator in the Life and Health Industry Park of the New North District. The building has 5 floors with a total construction area of approximately 10,000 square meters, with an investment budget of 150 million RMB. The R&D center occupies 5 floors and was officially put into use in March 2016. Currently, there are more than 60 employees, including over 10 senior expert consultants from the United States and Europe. Floors 1-4 are production lines for the Phase I project, designed in accordance with the cGMP standards of CFDA, EMA, and FDA. Currently, it is under construction and is scheduled to be completed in the second quarter of 2017, officially put into use in the second half of 2017. After the project is completed, it will be able to produce hundreds of kilograms of recombinant protein series bulk drugs and tens of millions of injection products annually. After the drug approval and market launch, the sales target during the production period will reach 500-1,000 million RMB.
Jianya Biotechnology’s Phase II industrialization base is located north of Liahe Road and west of Shishan Road in the New North District. It covers an area of 100 acres, with a planned investment of 450 million RMB, and the foundation stone was laid in September 2015. It will be designed and constructed according to the cGMP standards of CFDA, EMA, and FDA, featuring ton-scale fermentation tank production lines. The project is expected to start construction in the first half of 2017 to prepare for the large-scale production of insulin series products and their market launch.
With its world-leading industrialization technology, 20 years of domestic and foreign practical experience, industry high-level connections, and financial strength, Jianya Biotechnology will build a world-class 21st-century insulin ecological industrial park. It will rapidly achieve the industrialization, commercialization, and internationalization of insulin series products, providing high-quality and competitive insulin products to diabetic patients worldwide in the long term. It aims to break the long-term monopoly of imported insulin products in the Chinese market for the past 20 years, safeguard the safety of the medical and health system, and achieve a breakthrough in the international market for biopharmaceutical products entering Europe, America, and other countries.
2.Introduction to the Stainless Steel Flange Metal Hose and Flange Rubber Joint Contract for Phase I Project of Jianya Recombinant Protein Pharmaceuticals in Changzhou:
The following is the scan of the genuine contract. Please do not modify or reproduce it. This contract is only used as a proof of supply and is not for other purposes. Thank you for your cooperation.
3.Photograph of the Authentic Invoice for Stainless Steel Flange Metal Hose and Flange Rubber Expansion Joint for Phase I Project of Jianya Recombinant Protein Pharmaceuticals in Changzhou:
The following is a genuine photograph of the invoice for this contract. Please do not modify or reproduce it. This invoice is only used as proof of supply and is not for other purposes. Thank you for your cooperation